论文部分内容阅读
目的:研究糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效。方法:对自2014年12月至2015年11月间在我院采用糖皮质激素联合特布他林治疗的91例慢阻肺急性加重期患者进行回顾性研究,对患者治疗前后的SpO_2、PaO_2、PaCO_2、pH值等动脉血气指标值进行对比分析。结果:患者治疗后的SpO_2、PaO_2、PaCO_2、pH值等动脉血气指标都明显优于治疗前(P<0.05),比较对比差异值P<0.05,有统计学意义。治疗后患者的总有效率达95.6%。结论:对慢性阻塞性肺疾病的临床治疗中采用糖皮质激素联合特布他林能获得较好的治疗效果,值得临床推广应用。
Objective: To study the effect of glucocorticoids and terbutaline in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods: A retrospective study was conducted on 91 patients with COPD who were treated with glucocorticoids and terbutaline in our hospital from December 2014 to November 2015. The changes of SpO_2, PaO_2 , PaCO_2, pH and other arterial blood gas values were compared. Results: The arterial blood gas indexes such as SpO_2, PaO_2, PaCO_2 and pH were significantly better than those before treatment (P <0.05). The difference between the two groups was statistically significant (P <0.05). The total effective rate of patients after treatment reached 95.6%. Conclusion: The clinical treatment of chronic obstructive pulmonary disease with glucocorticoid combined with terbutaline can obtain better therapeutic effect, which is worthy of clinical application.